Breakthrough antibody therapy targets Alzheimer’s risk gene, offers hope for effective treatment Post author: Post published:October 6, 2023 Post category:uncategorized Researchers introduced and characterized a novel platform based on monoclonal antibodies (mAbs). You Might Also Like Study identifies key priorities for building mental health-friendly cities for young people March 26, 2024 Drug-related infant deaths surge in the U.S., study finds June 18, 2024 Study finds evidence for repurposing thiostrepton as an anti-rhabdomyosarcoma drug October 27, 2025
Study identifies key priorities for building mental health-friendly cities for young people March 26, 2024